An Interview with Insub Song

[Article Title]

Samsung Biologics' VP and Head of Procurement, Insub Song, pulls back the curtain on how one of the industry's leading CDMOs stays ahead of geopolitical disruptions, climate risks, and sudden demand surges. From AI-powered forecasting and digital twin technology to a bold new U.S. manufacturing expansion, Song reveals the strategies redefining supply chain resilience. He also shares how sustainability and ESG accountability are no longer optional, as they are now central to how Samsung Biologics selects suppliers and designs its operations. Read the full breakdown of the frameworks and innovations positioning Samsung Biologics for the next era of global biopharma.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.